Press Release: Casma : Casma Therapeutics Announces Publication in Science Advances Highlighting Novel Mechanism Related to TFEB Activation and Lysosomal Biology
Study demonstrates GABARAP-dependent TFEB activation plays a key role in regulating lysosomal homeostasisStudy demonstrates GABARAP-dependent TFEB activation plays a key role in regulating lysosomal homeostasis
Read full article »
Casma is a Massachusetts-based biotechnology company that develops therapies for the treatment of cancer, inflammation, neurodegeneration, and metabolic disorders.
Read more